Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
This is the complete answer, not a partial one — the list is never padded.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| R. LaDuane Clifton | $477,307 | $0 | $1,260,373 | $1,117,274 | $0 | $0 | $966,970 | $3,821,924 |
| Former Chief Financial Officer and Treasurer | ||||||||
| Neil McFarlane | 729,167 | 0 | 874,125 | 1,748,250 | 418,950 | 0 | 11,550 | 3,782,042 |
| President, Chief Executive Officer and Director | ||||||||
| Rahsaan Thompson | 466,667 | 50,000 | 272,680 | 545,360 | 178,600 | 0 | 58,067 | 1,571,374 |
| Chief Legal Officer, Secretary and Compliance Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| R. LaDuane Clifton | $3,821,924 | — | — | — |
| Neil McFarlane | 3,782,042 | — | — | — |
| Rahsaan Thompson | 1,571,374 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
No insider equity transactions reported since the proxy statement.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Neil McFarlane | PSU | 466,667 | — | $4,181,336 |
| Rahsaan Thompson | Option | 83,486 | 7.17 | — |
| Rahsaan Thompson | Option | 82,423 | 9.06 | — |
| Neil McFarlane | PSU | 72,500 | — | 649,600 |
| Rahsaan Thompson | Option | 2,250 | 8.26 | — |
| Rahsaan Thompson | Option | 10,000 | 42.56 | — |
| Rahsaan Thompson | PSU | 133,334 | — | 1,194,673 |
| Rahsaan Thompson | Option | 3,125 | 201.92 | — |
| Neil McFarlane | PSU | 112,500 | — | 1,008,000 |
| Rahsaan Thompson | Option | 4,687 | 56.8 | — |
| Neil McFarlane | PSU | 100,000 | — | 896,000 |
| Rahsaan Thompson | Option | 4,687 | 88 | — |
| Rahsaan Thompson | Option | 68,000 | 8.02 | — |
| Rahsaan Thompson | PSU | 34,000 | — | 304,640 |
| Rahsaan Thompson | PSU | 20,000 | — | 179,200 |
| Neil McFarlane | Option | 300,000 | 4.75 | — |
| Rahsaan Thompson | Option | 10,000 | 5.98 | — |
| Rahsaan Thompson | Option | 459,726 | 4.54 | — |
Our executive compensation program has been designed to motivate, reward, attract and retain high caliber management deemed essential to ensure our success. The program seeks to align executive compensation with our short- and long-term objectives, business strategy and financial performance. We intend that the total compensation of our NEOs reflects a 'pay for performance' compensation philosophy.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Alpine Rewards, LLC |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-04 | 45,947,281 | 234,753 | 144,582 | 99.49% | Passed |
| 2024 | 2024-05-13 | 11,167,215 | 9,888,153 | 273,661 | 53.04% | Passed |
| 2021 | 2021-06-17 | 6,845,736 | 1,287,944 | 159,450 | 84.17% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-06-04 | 99.49%a |
| 2024 | 2024-05-13 | 53.04%b |
| 2021 | 2021-06-17 | 84.17%c |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
c. Voting standard not stated in the filing.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Tamara A. FavoritoIndependent · Board Chair · Audit (Chair) | $117,500 | — | $187,178 | — | — | $304,678 |
| Alicia SecorIndependent · Audit · Compensation · Newly elected | 5,299 | — | 259,579 | — | — | 264,878 |
| Thomas D. AndersonIndependent · Compensation (Chair) · Nominating and Corporate Governance | 65,000 | — | 187,178 | — | — | 252,178 |
| Corey WattonIndependent · Audit · Compensation | 62,500 | — | 187,178 | — | — | 249,678 |
| John B. BodeIndependent · Not standing for re-election | 59,735 | — | 187,178 | — | — | 246,913 |
| Alvin Shih, M.DIndependent | 57,500 | — | 187,178 | — | — | 244,678 |
| Douglas W. CalderIndependent · Compensation · Nominating and Corporate Governance (Chair) | 56,814 | — | 187,178 | — | — | 243,992 |
| Wendy DixonIndependent | 50,516 | — | 187,178 | — | — | 237,694 |
| Wendy Dixon, Ph.DIndependent · Not standing for re-election · Departed during FY | 50,516 | — | 187,178 | — | — | 237,694 |
| Annual cash retainer | $45,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 22,500 / 15,000 / 12,500 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $525,380 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $525,380 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Zevra Therapeutics | 2025 | Neil McFarlane | $729,167 | $874,125 | $1,748,250 | $418,950 | $3,782,042 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, R. LaDuane Clifton | DEF 14A | 2026-04-20 | 0001434647-26-000025 | Section “Executive Compensation”. As printed: 3,821,924. Filing ↗machine: span 592019–592028 |
| 2 | Section 01, Neil McFarlane | DEF 14A | 2026-04-20 | 0001434647-26-000025 | Section “Executive Compensation”. As printed: 3,782,042. Filing ↗machine: span 580756–580765 |
| 3 | Section 01, Rahsaan Thompson | DEF 14A | 2026-04-20 | 0001434647-26-000025 | Section “Executive Compensation”. As printed: 1,571,374. Filing ↗machine: span 587532–587541 |
| 4 | Section 08, Tamara A. Favorito | DEF 14A | 2026-04-20 | 0001434647-26-000025 | Section “Director Compensation”. As printed: 304,678. Filing ↗machine: span 763596–763841 |
| 5 | Section 08, Alicia Secor | DEF 14A | 2026-04-20 | 0001434647-26-000025 | Section “Director Compensation”. As printed: 264,878. Filing ↗machine: span 765980–766225 |
| 6 | Section 08, Thomas D. Anderson | DEF 14A | 2026-04-20 | 0001434647-26-000025 | Section “Director Compensation”. As printed: 252,178. Filing ↗machine: span 754299–754544 |
| 7 | Section 08, Corey Watton | DEF 14A | 2026-04-20 | 0001434647-26-000025 | Section “Director Compensation”. As printed: 249,678. Filing ↗machine: span 771007–771252 |
| 8 | Section 08, John B. Bode | DEF 14A | 2026-04-20 | 0001434647-26-000025 | Section “Director Compensation”. As printed: 246,913. Filing ↗machine: span 756681–756926 |
| 9 | Section 08, Alvin Shih, M.D | DEF 14A | 2026-04-20 | 0001434647-26-000025 | Section “Director Compensation”. As printed: 244,678. Filing ↗machine: span 768367–768612 |
| 10 | Section 08, Douglas W. Calder | DEF 14A | 2026-04-20 | 0001434647-26-000025 | Section “Director Compensation”. As printed: 243,992. Filing ↗machine: span 758942–759187 |
| 11 | Section 08, Wendy Dixon | DEF 14A | 2026-04-20 | 0001434647-26-000025 | Section “Director Compensation”. As printed: 237,694. Filing ↗machine: span 761333–761578 |
| 12 | Section 08, Wendy Dixon, Ph.D | DEF 14A | 2026-04-20 | 0001434647-26-000025 | Section “Director Compensation”. As printed: 237,694. Filing ↗machine: span 761333–761578 |
| 13 | Section 06, 2026 vote | Form 8-K | 2026-06-05 | 0001434647-26-000041 | Item 5.07 · say-on-pay result. As reported: 99.49% (votes for as printed: 45,947,281). Filing ↗ |
| 14 | Section 06, 2024 vote | Form 8-K | 2024-05-13 | 0001437749-24-016275 | Item 5.07 · say-on-pay result. As reported: 53.04% (votes for as printed: 11,167,215). Filing ↗ |
| 15 | Section 06, 2021 vote | Form 8-K | 2021-06-24 | 0001437749-21-015558 | Item 5.07 · say-on-pay result. As reported: 84.17% (votes for as printed: 6,845,736). Filing ↗ |
| 16 | Section 09b board cost (computed) | Computed | — | computed | Cash 525,380 + equity 0 + all other 0 = 525,380, summed across the director compensation table rows.machine: formula: Σ = 525,380 |
| 17 | Zevra Therapeutics (subject), Section 10b CEO total | DEF 14A | 2026-04-20 | 0001434647-26-000025 | CEO total compensation as printed in Zevra Therapeutics's own proxy. As printed: 3,782,042. Filing ↗machine: span 580756–580765 |